Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Evofem Biosciences News

    0,0168 $ +17,96% +0,0026 $
    In : 0,0157 € | 26.04.24 21:58:42 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3D9Z3
    ISIN: US30048L3024
    US-Symbol: EVFM
    Typ: Aktie

    Evofem Biosciences News

    18.04.24 - PR Newswire
    Evofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO
    Evofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO PR Newswire
    27.03.24 - PR Newswire
    Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023
    Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 PR Newswire
    20.03.24 - PR Newswire
    Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-Cal
    Evofem Negotiates Improved Rebate for Hormone-​Free "In the Moment" Contraceptive PHEXXI with Medi-Cal PR Newswire
    07.03.24 - PR Newswire
    For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy
    For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-​Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy ...
    01.02.24 - PR Newswire
    Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023
    Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023 PR Newswire
    08.01.24 - PR Newswire
    Washington State HCA Removes Prior Authorization for Hormone-Free "In the Moment" Contraceptive PHEXXI Ahead of Huskies vs. Wolverines Championship Game
    Washington State HCA Removes Prior Authorization for Hormone-​Free "In the Moment" Contraceptive PHEXXI Ahead of Huskies vs. Wolverines Championship Game PR Newswire
    19.12.23 - PR Newswire
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, EVFM, AEZS, HOLI
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, EVFM, AEZS, HOLI PR Newswire
    13.12.23 - PR Newswire
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSTR, CVLY, EVFM, EAR
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSTR, CVLY, EVFM, EAR PR Newswire
    12.12.23 - PR Newswire
    Shareholder Alert: Ademi LLP investigates whether Evofem Biosciences, Inc. has obtained a Fair Price in its transaction with Aditxt
    Shareholder Alert: Ademi LLP investigates whether Evofem Biosciences, Inc. has obtained a Fair Price in its transaction with Aditxt PR Newswire
    14.11.23 - PR Newswire
    Evofem Biosciences Announces Financial Results for the Third Quarter of 2023
    Evofem Biosciences Announces Financial Results for the Third Quarter of 2023 PR Newswire
    24.10.23 - PR Newswire
    Evofem Biosciences Announces Preliminary Results for the Third Quarter of 2023
    Evofem Biosciences Announces Preliminary Results for the Third Quarter of 2023 PR Newswire
    13.10.23 - PR Newswire
    Evofem to Participate in the Virtual Investor Ask the CEO Conference
    Evofem to Participate in the Virtual Investor Ask the CEO Conference PR Newswire
    27.09.23 - PR Newswire
    Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents Expire
    Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents Expire PR Newswire
    11.09.23 - PR Newswire
    Evofem Biosciences Successfully Amends S.P.A. with Institutional Investor
    Evofem Biosciences Successfully Amends S.P.A. with Institutional Investor PR Newswire
    22.08.23 - PR Newswire
    Evofem Biosciences Signs Non-Binding Letter of Intent to Enable Listing on a National Stock Exchange
    Evofem Biosciences Signs Non-​Binding Letter of Intent to Enable Listing on a National Stock Exchange PR Newswire
    14.08.23 - PR Newswire
    Evofem Biosciences Announces Financial Results for the Second Quarter of 2023
    Evofem Biosciences Announces Financial Results for the Second Quarter of 2023 PR Newswire
    06.07.23 - PR Newswire
    Evofem to Participate in the Virtual Investor Summer Spotlight Series
    Evofem to Participate in the Virtual Investor Summer Spotlight Series PR Newswire
    16.06.23 - PR Newswire
    Evofem Biosciences Announces Financial Results for the First Quarter of 2023
    Evofem Biosciences Announces Financial Results for the First Quarter of 2023 PR Newswire
    01.06.23 - PR Newswire
    Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023
    Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023 PR Newswire
    17.05.23 - PR Newswire
    Evofem Biosciences Announces 1-for-125 Reverse Stock Split
    Evofem Biosciences Announces 1-for-125 Reverse Stock Split PR Newswire

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »